ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program.

Source:http://linkedlifedata.com/resource/pubmed/id/21216447

Download in:

View as

General Info

PMID
21216447